Skip to main content

Effects of cannabinoid receptor activation by CP55,940 on normal bladder function and irritation-induced bladder overactivity in non-awake anaesthetised rats

Abstract

Introduction and hypothesis

This study was designed to evaluate the effects of CP55,940 on normal bladder function in vivo and examine whether it suppresses urinary frequency induced by nociceptive stimuli in the bladder. Cannabinoid receptor (CBR) activity may be involved in the regulation of bladder function. However, the role of CBR subtypes in micturition has yet to be established. CP55,940 is a synthetic analogue of tetrahydrocannabidiol, which is a psychoactive ingredient of the Cannabis plant.

Methods

Cystometry under urethane anaesthesia was performed to evaluate the effect of intravesical delivery of CP55,940 with or without administration of CB1 antagonist AM251 or CB2 antagonist AM630 on bladder function in female rats. The effects of CP55,940 were also examined in rats with urinary irritation induced by intravesical infusion of acetic acid.

Results

Infusion of CP55,940 significantly (p < 0.05) increased micturition interval (MI) and bladder capacity (BC) by 52 % and decreased maximal voiding pressure (MP) by 25 %. Pretreatment with AM251 or AM630 before CP55,940 administration prevented CP55,940-induced increases in MI, BC and reduced MP. Acetic acid induced urinary frequency as evidenced by a reduction in MI and was suppressed by CP55,940.

Conclusions

CP55,940 decreases bladder activity and urinary frequency induced by nociceptive stimuli, probably by suppression of bladder afferent activity. Effects of CP55,940 were abolished by both CBR antagonists. This data implicates a role for the endocannabinoid system in bladder mechanoafferent function in rats. In addition, our results show that CP55,940 reverses urinary frequency exemplified in an overactive bladder model, suggesting it could be an effective treatment for patients with lower urinary tract symptoms.

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2
Fig. 3

References

  1. Freeman RM, Adekanmi O, Waterfield MR, Waterfield AE, Wright D, Zajicek J (2006) The effect of cannabis on urge incontinence in patients with multiple sclerosis: a multicentre, randomised placebo-controlled trial (CAMS-LUTS). Int Urogynecol J Pelvic Floor Dysfunct 17(6):636–41

    CAS  Article  PubMed  Google Scholar 

  2. Pertwee RG, Howlett AC, Abood ME et al (2010) International union of basic and clinical pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB1 and CB2. Pharmacol Rev 62(4):588–631

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  3. Bakali E, Elliott RA, Taylor AH, Willets J, Konje JC, Tincello DG (2013) Distribution and function of the endocannabinoid system in the rat and human bladder. Int Urogynecol J Pelvic Floor Dysfunct 24(5):855–63

    Article  Google Scholar 

  4. Mukerji G, Yiangou Y, Agarwal SK, Anand P (2010) Increased cannabinoid receptor 1-immunoreactive nerve fibers in overactive and painful bladder disorders and their correlation with symptoms. Urology 75(6):1514.e15-20

    Article  PubMed  Google Scholar 

  5. Hiragata S, Ogawa T, Hayashi Y et al (2007) Effects of IP-751, ajulemic acid, on bladder overactivity induced by bladder irritation in rats. Urology 70(1):202–8

    Article  PubMed  Google Scholar 

  6. Dmitrieva N, Berkley KJ (2002) Contrasting effects of WIN 55212-2 on motility of the rat bladder and uterus. J Neurosci 22(16):7147–53

    CAS  PubMed  Google Scholar 

  7. Kakizaki H, de Groat WC (1996) Role of spinal nitric oxide in the facilitation of the micturition reflex by bladder irritation. J Urol 155(1):355–60

    CAS  Article  PubMed  Google Scholar 

  8. Zhang X, Igawa Y, Ishizuka O, Nishizawa O, Andersson K-E (2003) Effects of resiniferatoxin desensitization of capsaicin-sensitive afferents on detrusor over-activity induced by intravesical capsaicin, acetic acid or ATP in conscious rats. Naunyn Schmiedebergs Arch Pharmacol 367(5):473–9

    CAS  Article  PubMed  Google Scholar 

  9. Hino K, Honjo H, Nakao M, Kitakoji H (2010) The effects of sacral acupuncture on acetic acid-induced bladder irritation in conscious rats. Urology 75(3):730–4

    Article  PubMed  Google Scholar 

  10. Mally AD, Matsuta Y, Zhang F et al (2013) Role of opioid and metabotropic glutamate 5 receptors in pudendal inhibition of bladder overactivity in cats. J Urol 189(4):1574–9

    CAS  Article  PubMed  Google Scholar 

  11. Gratzke C, Streng T, Park A et al (2009) Distribution and function of cannabinoid receptors 1 and 2 in the rat, monkey and human bladder. J Urol 181(4):1939–48

    CAS  Article  PubMed  Google Scholar 

  12. Malan TP, Ibrahim MM, Deng H et al (2001) CB2 cannabinoid receptor-mediated peripheral antinociception. Pain 93(3):239–45

    CAS  Article  PubMed  Google Scholar 

  13. Castroman PJ, Ness TJ (2002) Ketamine, an N-methyl-D-aspartate receptor antagonist, inhibits the spinal neuronal responses to distension of the rat urinary bladder. Anesthesiology 96(6):1410–9

    CAS  Article  PubMed  Google Scholar 

  14. Ozkurkcugil C, Ozkan L (2010) Effects of anesthetics on cystometric parameters in female rats. Int Urol Nephrol 42(4):909–13

    CAS  Article  PubMed  Google Scholar 

  15. Gratzke C, Streng T, Stief CG et al (2010) Effects of cannabinor, a novel selective cannabinoid 2 receptor agonist, on bladder function in normal rats. Eur Urol 57:1093–100

    Article  PubMed  Google Scholar 

  16. Tyagi V, Philips BJ, Su R et al (2009) Differential expression of functional cannabinoid receptors in human bladder detrusor and urothelium. J Urol 181(4):1932–8

    CAS  Article  PubMed  Google Scholar 

  17. Di Marzo V, Bifulco M, De Petrocellis L (2004) The endocannabinoid system and its therapeutic exploitation. Nat Rev Drug Discov 3(9):771–84

    Article  PubMed  Google Scholar 

  18. Pertwee RG, Fernando SR (1996) Evidence for the presence of cannabinoid CB1 receptors in mouse urinary bladder. Br J Pharmacol 118(8):2053–8

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  19. Jaggar SI, Hasnie FS, Sellaturay S, Rice AS (1998) The anti-hyperalgesic actions of the cannabinoid anandamide and the putative CB2 receptor agonist palmitoylethanolamide in visceral and somatic inflammatory pain. Pain 76(1-2):189–99

    CAS  Article  PubMed  Google Scholar 

  20. Daly DM, Collins VM, Chapple CR, Grundy D (2011) The afferent system and its role in lower urinary tract dysfunction. Curr Opin Urol 21(4):268–74

    Article  PubMed  Google Scholar 

  21. Sanchez Freire V, Burkhard FC, Kessler TM, Kuhn A, Draeger A, Monastyrskaya K (2010) MicroRNAs may mediate the down-regulation of neurokinin-1 receptor in chronic bladder pain syndrome. Am J Pathol 176(1):288–303

    Article  PubMed  PubMed Central  Google Scholar 

  22. Merriam FV, Wang ZY, Guerios SD, Bjorling DE (2008) Cannabinoid receptor 2 is increased in acutely and chronically inflamed bladder of rats. Neurosci Lett 445(1):130–4

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  23. Walczak JS, Cervero F (2011) Local activation of cannabinoid CB1 receptors in the urinary bladder reduces the inflammation-induced sensitization of bladder afferents. Mol Pain 7:31

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  24. Pertwee R, Griffin G, Fernando S, Li X, Hill A, Makriyannis A (1995) AM630, a competitive cannabinoid receptor antagonist. Life Sci 56(23-24):1949–55

    CAS  Article  PubMed  Google Scholar 

  25. Gatley SJ, Lan R, Pyatt B, Gifford AN, Volkow ND, Makriyannis A (1997) Binding of the non-classical cannabinoid CP 55,940, and the diarylpyrazole AM251 to rodent brain cannabinoid receptors. Life Sci 61(14):PL 191-7

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This study was funded by a Wellbeing of Women Training Research Fellowship awarded to Dr E Bakali.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Evangelia Bakali.

Ethics declarations

Conflicts of interest

None.

Financial disclaimers

Professor Lambert is an administration director for Brit J. Anaesthesia.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Bakali, E., Mbaki, Y., Lambert, D.G. et al. Effects of cannabinoid receptor activation by CP55,940 on normal bladder function and irritation-induced bladder overactivity in non-awake anaesthetised rats. Int Urogynecol J 27, 1393–1400 (2016). https://doi.org/10.1007/s00192-016-2984-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00192-016-2984-x

Keywords

  • Cannabinoid receptors
  • Cystometry
  • Urinary bladder
  • Overactive bladder